Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding ...

Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly twofold, with females more likely than males to report feeling either ...

HonorHealth Research Institute's new downtown Phoenix laboratory has produced its first study, centered on a promising new ...